J-CHS criteria | Sensitivity | Specificity | PPV | NPV | LR + | LR- | AUC ROC (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Frailty | Non-frailty | Crude | Bootstrap | |||||||||||
KCL | ||||||||||||||
Total (n = 1306) | ||||||||||||||
Frailty, n | 112 | (8.6) | 233 | (17.8) | 76.2 | 79.9 | 32.5 | 96.4 | 3.8 | 0.3 | 0.861 | (0.832–0.889) | 0.840 | (0.808–0.871) |
Non-frailty, n | 35 | (2.7) | 926 | (70.9) | ||||||||||
Women (n = 656) | ||||||||||||||
Frailty, n | 59 | (9.0) | 110 | (16.8) | 73.8 | 80.9 | 34.9 | 95.7 | 3.9 | 0.3 | 0.851 | (0.809–0.892) | 0.831 | (0.784–0.879) |
Non-frailty, n | 21 | (3.2) | 466 | (71.0) | ||||||||||
Men (n = 650) | ||||||||||||||
Frailty, n | 53 | (8.2) | 123 | (18.9) | 79.1 | 78.9 | 30.1 | 97.0 | 3.7 | 0.3 | 0.875 | (0.839–0.911) | 0.856 | (0.815–0.898) |
Non-frailty, n | 14 | (2.1) | 460 | (70.8) | ||||||||||
FSI | ||||||||||||||
Total (n = 1306) | ||||||||||||||
Frailty, n | 129 | (9.9) | 321 | (24.5) | 87.8 | 72.3 | 28.7 | 97.9 | 3.2 | 0.2 | 0.860 | (0.831–0.889) | 0.780 | (0.728–0.833) |
Non-frailty, n | 18 | (1.4) | 838 | (64.2) | ||||||||||
Women (n = 656) | ||||||||||||||
Frailty, n | 68 | (10.4) | 170 | (25.9) | 85.0 | 70.5 | 28.6 | 97.1 | 2.9 | 0.2 | 0.837 | (0.796–0.879) | 0.752 | (0.695–0.810) |
Non-frailty, n | 12 | (1.8) | 406 | (61.9) | ||||||||||
Men (n = 650) | ||||||||||||||
Frailty, n | 61 | (9.4) | 151 | (23.2) | 91.0 | 74.1 | 28.8 | 98.6 | 3.5 | 0.1 | 0.885 | (0.846–0.925) | 0.848 | (0.791–0.904) |
Non-frailty, n | 6 | (0.9) | 432 | (66.5) | ||||||||||
Self-reported health | ||||||||||||||
Total (n = 1306) | ||||||||||||||
Frailty, n | 54 | (4.2) | 110 | (8.4) | 36.7 | 90.5 | 32.9 | 91.9 | 3.9 | 0.7 | 0.668 | (0.629–0.707) | 0.405 | (0.336–0.473) |
Non-frailty, n | 93 | (7.1) | 1,049 | (80.3) | ||||||||||
Women (n = 656) | ||||||||||||||
Frailty, n | 27 | (4.1) | 50 | (7.6) | 33.8 | 91.3 | 35.1 | 90.8 | 3.9 | 0.7 | 0.665 | (0.616–0.714) | 0.407 | (0.311–0.504) |
Non-frailty, n | 53 | (8.1) | 526 | (80.2) | ||||||||||
Men (n = 650) | ||||||||||||||
Frailty, n | 27 | (4.2) | 60 | (9.2) | 40.3 | 89.7 | 31.0 | 92.9 | 3.9 | 0.7 | 0.672 | (0.610–0.734) | 0.430 | (0.335–0.526) |
Non-frailty, n | 40 | (6.1) | 523 | (80.5) |